Features of Adipokines Metabolism in Women with Arterial Hypertension and Obesity, Depending on the Left Ventricular Diastolic Function
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Abstract
Diastolic dysfunction is often associated with heart failure with a preserved ejection fraction, obesity and often observed in females. The association of adipokines blood levels with diastolic left ventricular dysfunction remains poorly understood.
The objective: study of the features of adipokine levels in women with obesity and arterial hypertension depending on the diastolic function.
Materials and methods. The study involved 82 patients. Patients with normal diastolic function were assigned to group 1, patients with diastolic dysfunction of the 1st degree – to group 2, and patients with diastolic dysfunction of the 2nd degree – to group 3. Blood levels of adipokines were measured in all patients.
Results. The average age of the study group was 51.2±4.4 years. Patients with normal diastolic function had significantly lower plasma leptin levels compared with patients with grade 1 and 2 diastolic dysfunction: 13.3 ng/ml compared to 18.7 ng/ml for grade 1 DD and 24.4 ng/ml at 2 grade of DD (p<0.01). Also, patients with DD 2 grade had a significantly higher level of leptin than patients with grade 1 of DD (p<0.05). Adiponectin levels in patients with normal diastolic function were significantly higher than in patients with grade 2 of DD (p<0.05).
Conclusion. In women with arterial hypertension and obesity aged 40–60, there is an association of an increase in blood leptin with an increase in the degree of diastolic disorders of the left ventricular. A significant decrease of adiponectin level in this patients was only in pseudo normal type of left ventricular diastolic dysfunction.##plugins.themes.bootstrap3.article.details##
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright and grant the journal the first publication of original scientific articles under the Creative Commons Attribution 4.0 International License, which allows others to distribute work with acknowledgment of authorship and first publication in this journal.
References
Драпкина О.М. Шепель Р.Н., Деева Т.А. Оценка уровня лептина в сыворотке крови у пациентов с метаболическим синдромом и гипертрофией миокарда левого желудочка. Рациональная фармакотерапия в кардиологии 2018;14(1):27-33.
Рекомендації з ехокардіографічної оцінки діастолічної функції лівого шлуночка [Електронний ресурс] / [В.М. Коваленко, О.С. Сичов, М.М. Долженко та ін.]. – 2018. – Режим доступу до ресурсу: http://amosovinstitute.org.ua/wp-content/uploads/2018/11/Rekomendatsiyi-diastola.pdf.
Шаронова Л.А., Вербовой А.Ф., Цанава И.А., Вербовая Н.И. Влияние уровней адипонектина и лептина в сыворотке крови на ремоделирование миокарда у больных с сахарным диабетом 2-го типа и подагрой. Клин. мед. 2016; 94(2): 120–127.
Aljaroudi W, Halley C, Houghtaling P, et al. Impact of body mass index on diastolic function in patients with normal left ventricular ejection fraction. Nutr Diabetes 2012;2:e39
Attanasio P, Anker SD, Doehner W, von Haehling S. Hormonal consequences and prognosis of chronic heart failure. Curr Opin Endocrinol Diabetes Obes. 2011;18:224–30.
Borlaug BA, Paulus WJ. Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. Eur Heart J. 2011;32:670–9
Canepa M, Strait JB, Abramov D, et al. Contribution of central adiposity to left ventricular diastolic function (from the Baltimore Longitudinal Study of Aging). Am J Cardiol 2012;109:1171-8
Caulin-Glaser T, Garcia-Cardena G, Sarrel P, et al. 17 beta-estradiol regulation of human endothelial cell basal nitric oxide release, independent of cytosolic Ca2+ mobilization. Circ Res 1997;81:885-92
Chow WS, Cheung BMY, Tso AWK, et al. Hypoadiponectinemia as a predictor for the development of hypertension: a 5-year prospective study. Hypertension. 2007;49:1455–61.
Cornier MA, Despres JP, Davis N, et al. Assessing adiposity: a scientific statement from the American Heart Association. Circulation 2011;124:1996-2019
Duda MK, O’Shea KM, Lei B, et al. Dietary supplementation with omega-3 PUFA increases adiponectin and attenuates ventricular remodeling and dysfunction with pressure overload. Cardiovasc Res 2007;76:303-10
Falcao-Pires I, Castro-Chaves P, Miranda-Silva D, et al. Physiological, pathological and potential therapeutic roles of adipokines. Drug Discov Today 2012;17:880-9
Fontes-Carvalho, R., Pimenta, J., Bettencourt, P., et al. (2015). Association between plasma leptin and adiponectin levels and diastolic function in the general population. Expert Opinion on Therapeutic Targets, 19(10), 1283–1291
Han SH, Quon MJ, Kim JA, Koh KK. Adiponectin and cardiovascular disease: response to therapeutic interventions. J Am Coll Cardiol 2007;49:531-8
Hu G, Jousilahti P, Antikainen R, et al. Joint effects of physical activity, body mass index, waist circumference, and waist-to-hip ratio on the risk of heart failure. Circulation 2010;121:237-44
Koh KK, Park SM, Quon MJ. Leptin and cardiovascular disease: response to therapeutic interventions. Circulation 2008;117:3238-49
Lam CS, Lyass A, Kraigher-Krainer E, et al. Cardiac dysfunction and noncardiac dysfunction as precursors of heart failure with reduced and preserved ejection fraction in the community. Circulation 2011;124:24-30
Lam CSP, Donal E, Kraigher-Krainer E, Vasan RS. Epidemiology and clinical course of heart failure with preserved ejection fraction. Eur J Heart Fail. 2011;13:18–28.
Ling S, Dai A, Dilley RJ, et al. Endogenous estrogen deficiency reduces proliferation and enhances apoptosis related death in vascular smooth muscle cells: insights from the aromatase knockout mouse. Circulation 2004;109:537-43
Maggioni AP, Dahlström U, Filippatos G, et al. EUR observational research programme: regional differences and 1–year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot). Eur J Heart Fail. 2013;15:808–17.
Nagueh S.F., Smiseth O.A., Appleton C.P. et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: An update from the American society of echocardiography and the European association of cardiovascular imaging. // J Am Soc Echocardiogr. – 2016. – N 4. – P. 277-314.
Negi SI, Jeong EM, Shukrullah I, et al. Association of low plasma adiponectin with early diastolic dysfunction. Congestive heart failure 2012;18:187-91
Nigro E, Scudiero O, Monaco ML et al. New insight into adiponectin role in obesity and obesity-related diseases. Biomed Res Int. 2014;2014:658913.
Norvik, J. V., Schirmer, H., Ytrehus, K., et al. (2017). Low adiponectin is associated with diastolic dysfunction in women: a cross-sectional study from the Tromsø Study. BMC Cardiovascular Disorders, 17(1)
Nugraha, Fauzi, Akbar, M., Aprami, Toni & Martha, Januar. (2019). Correlation between Leptin with Diastolic Function in Young Adult Obesity. ACI (Acta Cardiologia Indonesiana). 5. 54.
Persson J, Lindberg K, Gustafsson TP, et al.. Low plasma adiponectin concentration is associated with myocardial infarction in young individuals. J Intern Med. 2010;268:194–205.
Pischon T, Boeing H, Hoffmann K, et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med 2008;359:2105-20
Pischon T, Girman CJ, Hotamisligil GS, et al. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004;291:1730-7
Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2016;37:2129–2200m.
Puurunen, V. P., Lepojärvi, E. S., Piira, O. P., et al. (2016). High plasma leptin levels are associated with impaired diastolic function in patients with coronary artery disease. Peptides, 84, 17–21.
Redfield MM, Jacobsen SJ, Burnett JC, et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA. 2003;289:194–202.
Reis SE, Gloth ST, Blumenthal RS, et al. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation 1994;89:52-60
Rega-Kaun G, Kaun C, Wojta J. More than a simple storage organ: adipose tissue as a source of adipokines involved in cardiovascular disease. Thromb Haemost. 2013;110:641–50.
Russo C, Jin Z, Homma S, et al. Effect of obesity and overweight on left ventricular diastolic function: a community-based study in an elderly cohort. J Am Coll Cardiol 2011;57:1368-74
Ryo M, Nakamura T, Kihara S, et al. Adiponectin as a biomarker of the metabolic syndrome. Circ J. 2004;68:975–81.
Sattar N, Wannamethee G, Sarwar N, et al. Leptin and coronary heart disease: prospective study and systematic review. J Am Coll Cardiol 2009;53:167-75
Shibata R, Ouchi N, Ito M, et al. Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat Med 2004;10:1384-9
Wannamethee SG, Shaper AG, Whincup PH, et al. Obesity and risk of incident heart failure in older men with and without pre-existing coronary heart disease: does leptin have a role? J Am Coll Cardiol 2011;58:1870-7
Williams, B., Mancia, G., Spiering, W., et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. European Heart Journal. European Heart Journal, Volume 34, Issue 28, 21 July 2013, Pages 2159–2219
Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure. J Am Coll Cardiol. 2013;62:e147–239.
